Mark Whittaker

5.4k total citations · 1 hit paper
107 papers, 4.3k citations indexed

About

Mark Whittaker is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Mark Whittaker has authored 107 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 36 papers in Organic Chemistry and 24 papers in Oncology. Recurrent topics in Mark Whittaker's work include Peptidase Inhibition and Analysis (16 papers), Protease and Inhibitor Mechanisms (14 papers) and Chemical Synthesis and Analysis (11 papers). Mark Whittaker is often cited by papers focused on Peptidase Inhibition and Analysis (16 papers), Protease and Inhibitor Mechanisms (14 papers) and Chemical Synthesis and Analysis (11 papers). Mark Whittaker collaborates with scholars based in United Kingdom, Germany and United States. Mark Whittaker's co-authors include Christopher D. Floyd, Peter de Nully Brown, A. J. H. Gearing, R. Paul Beckett, Leon Black, Heather Tye, Alan H. Drummond, Osamu Ichihara, Thomas Hesterkamp and Richard Law and has published in prestigious journals such as Chemical Reviews, Journal of the American Chemical Society and Chemical Society Reviews.

In The Last Decade

Mark Whittaker

107 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors

1999 851 citations Mark Whittaker, Peter de Nully Brown et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Whittaker United Kingdom	34	1.9k	1.4k	1.2k	945	477	107	4.3k
Franco Zunino Italy	57	6.0k 3.2×	1.5k 1.1×	3.0k 2.5×	676 0.7×	2.5k 5.3×	306	11.1k
Hideaki Nakamura Japan	31	2.8k 1.5×	536 0.4×	678 0.6×	463 0.5×	112 0.2×	94	7.3k
Shao‐Chun Wang United States	39	3.1k 1.6×	262 0.2×	1.6k 1.3×	812 0.9×	64 0.1×	149	6.1k
Lihong Shi China	33	1.7k 0.9×	395 0.3×	1.0k 0.9×	658 0.7×	77 0.2×	118	3.5k
Haichao Zhang United States	31	3.7k 1.9×	431 0.3×	1.1k 0.9×	343 0.4×	27 0.1×	90	5.0k
Xuan Huang China	40	2.3k 1.2×	743 0.5×	743 0.6×	887 0.9×	77 0.2×	119	4.4k
Pengyu Yang China	30	1.5k 0.8×	1.0k 0.8×	257 0.2×	232 0.2×	44 0.1×	85	3.0k
Jingwen Liu China	39	2.6k 1.4×	104 0.1×	997 0.8×	845 0.9×	61 0.1×	159	5.6k
Helen M. Coley United Kingdom	34	1.7k 0.9×	285 0.2×	1.4k 1.1×	443 0.5×	33 0.1×	78	3.9k
Hailing Li China	31	966 0.5×	337 0.2×	146 0.1×	558 0.6×	57 0.1×	209	3.7k

Countries citing papers authored by Mark Whittaker

Since Specialization

Citations

This map shows the geographic impact of Mark Whittaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Whittaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Whittaker more than expected).

Fields of papers citing papers by Mark Whittaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Whittaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Whittaker. The network helps show where Mark Whittaker may publish in the future.

Co-authorship network of co-authors of Mark Whittaker

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Whittaker. A scholar is included among the top collaborators of Mark Whittaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Whittaker. Mark Whittaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jen, Gabriel, et al.. (2018). The synthesis and hydration of ternesite, Ca5(SiO4)2SO4. Cement and Concrete Research. 113. 27–40. 38 indexed citations

Louërat, Frédéric, et al.. (2011). TBAF-Catalysed silver oxide-mediated cross-coupling of functional trimethysilylpyridines: access to arylpyridines and bihetaryl compounds. Organic & Biomolecular Chemistry. 9(6). 1768–1768. 16 indexed citations

Tye, Heather, J. Prestle, Stefan Scheuerer, et al.. (2010). Novel 6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohepta[f]indene analogues as potent and selective 5-HT2C agonists for the treatment of metabolic disorders. Bioorganic & Medicinal Chemistry Letters. 21(1). 34–37. 21 indexed citations

East, Stephen P., Christian Eickmeier, Adam Flegg, et al.. (2010). An orally bioavailable positive allosteric modulator of the mGlu4 receptor with efficacy in an animal model of motor dysfunction. Bioorganic & Medicinal Chemistry Letters. 20(16). 4901–4905. 36 indexed citations

Keminer, Oliver, Jan D. Kahmann, Christoph Scheich, et al.. (2009). Novel MK2 Inhibitors by Fragment Screening. Combinatorial Chemistry & High Throughput Screening. 12(7). 697–703. 4 indexed citations

Czaplewski, Lloyd G., Ian Collins, David R. Brown, et al.. (2008). Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ. Bioorganic & Medicinal Chemistry Letters. 19(2). 524–527. 79 indexed citations

Wood, L M, et al.. (2006). Nupafant, a PAF‐antagonist prototype for suppression of ventricular fibrillation without liability for QT prolongation?. British Journal of Pharmacology. 149(3). 269–276. 4 indexed citations

Barker, John J., et al.. (2006). Fragment screening by biochemical assay. Expert Opinion on Drug Discovery. 1(3). 225–236. 39 indexed citations

Tye, Heather & Mark Whittaker. (2004). Use of a Design of Experiments approach for the optimisation of a microwave assisted Ugi reaction. Organic & Biomolecular Chemistry. 2(6). 813–813. 58 indexed citations

10.

East, Stephen P., R. Paul Beckett, John M. Clements, et al.. (2003). Peptide deformylase inhibitors with activity against respiratory tract pathogens. Bioorganic & Medicinal Chemistry Letters. 14(1). 59–62. 17 indexed citations

11.

Davies, Stephen J., Andrew Ayscough, R. Paul Beckett, et al.. (2003). Structure–activity relationships of the peptide deformylase inhibitor BB-3497: modification of the P2′ and P3′ side chains. Bioorganic & Medicinal Chemistry Letters. 13(16). 2715–2718. 19 indexed citations

12.

Whittaker, Mark, et al.. (2002). Mucinous metaplasia of the penis. Histopathology. 40(2). 177–179. 19 indexed citations

13.

Beer, Trevor W., et al.. (2000). Mitotic and in situ end-labeling apoptotic indices as prognostic markers in malignant mesothelioma. Annals of Diagnostic Pathology. 4(3). 143–148. 18 indexed citations

14.

Drummond, Alan H., Paul Beckett, Peter de Nully Brown, et al.. (1999). Preclinical and Clinical Studies of MMP Inhibitors in Cancer. Annals of the New York Academy of Sciences. 878(1). 228–235. 181 indexed citations

15.

Beckett, R. Paul & Mark Whittaker. (1998). Matrix metalloproteinase inhibitors 1998. Expert Opinion on Therapeutic Patents. 8(3). 259–282. 116 indexed citations

16.

Pratt, Lisa M., R. Paul Beckett, Dominic J. Corkill, et al.. (1998). The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement. Bioorganic & Medicinal Chemistry Letters. 8(11). 1359–1364. 18 indexed citations

17.

Whittaker, Mark. (1998). Discovery of protease inhibitors using targeted libraries. Current Opinion in Chemical Biology. 2(3). 386–396. 22 indexed citations

18.

Hodgkin, Edward E., A. L. Miller, & Mark Whittaker. (1993). A Monte Carlo pharmacophore generation procedure: Application to the human PAF receptor. Journal of Computer-Aided Molecular Design. 7(5). 515–534. 14 indexed citations

19.

Davies, Stephen G., et al.. (1992). Chiral organometallic NADH mimics: Highly stereoselective reductions of ethyl benzoylformate with a 1,4-dihydronicotinoyl fragment attached to the homochiral auxiliary [(η5-C5H5)Fe(CO)(PPh3)] and possessing a homochiral β-hydroxy-carboxamide at C-5.. Tetrahedron Asymmetry. 3(7). 871–901. 22 indexed citations

20.

Davies, Stephen G., George Bashiardes, R. Paul Beckett, et al.. (1988). Asymmetric synthesis via chiral transition metal auxiliaries. Philosophical Transactions of the Royal Society of London Series A Mathematical and Physical Sciences. 326(1592). 619–631. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact